A Crowd Sourcing Platform for Patients With Cancer
Part of paid clinical trials in Seattle, Washington.
- Sponsor
- All4Cure
- Study ID
- NCT03530826
- Status
- Recruiting
Conditions
- Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- No intervention — OTHERNo Intervention
Study Details
All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.
Key Dates
- Start date
- Apr 26, 2018
- Status verified
- Jul 2024
- Primary completion
- Jan 31, 2028
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 5,000 participants (estimated)
Primary Outcome Measure
Change in tumor tissue molecular profiles [ Time Frame: 6 years ]
Central Contacts
- Carl A Blau, MD2064121787
- Kimberly A Burton, PhD2069482711
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| All4Cure | Seattle | Washington | 98136 |
Find similar trials in Seattle, WA
By research site
Related Studies
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsPHASE1/PHASE2 · Recruiting · Immatics US, Inc. · Stanford, California
- Pan Tumor Rollover StudyPHASE2 · Recruiting · Bristol-Myers Squibb · Huntsville, Alabama